|Articles|January 28, 2011

Featured Search - 18F-FDG PET Predicts Outcome in Pediatric Brain Stem Glioma

Examination of baseline scans from a glioma-treatment trial of the Pediatric Brain Tumor Consortium shows that the pattern and intensity of uptake in 18F FDG uptake in children diagnosed with brainstem glioma correlated with overall and progression-free survival rates.

Top news from a Jan. 27 featured radiology search on SearchMedica: nuclear

Evaluation of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor ConsortiumThe Journal of Nuclear Medicine | Feb 1, 2011 (Free abstract. Full text $15)

Examination of baseline scans from a glioma-treatment trial of the Pediatric Brain Tumor Consortium shows that the pattern and intensity of uptake in ^18FFDG PET scans in children diagnosed with brainstem glioma correlated with overall and progression-free survival rates.

Related content from Diagnostic Imaging:

FDG-PET/CT identifies aortic dissection

PET/CT imaging with FDG can identify when a tear in the wall of the aorta causes blood to flow between the wall's layers and forces the layers apart.

FDG-PET/CT provides added value in routine multiple imaging scans

In patients with suspected infection and no known history of cancer FDG-PET/CT can be a useful tool for localizing the infectious disease.

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

October 6th, 2026

Interventional Radiology in Focus: A Closer Look at Prostatic Artery Embolization for Benign Prostatic Hyperplasia

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the utility of prostatic artery embolization for treating benign prostatic hyperplasia, key imaging considerations and pertinent technique pearls to help facilitate optimal outcomes.

October 6th, 2026

FDA Clears MRI-Based AI Software for Body Composition Analysis

The AI-powered SwiftSight Body Composition software reportedly provides automated quantification of muscle and adipose tissue after a brief MRI scan.

October 5th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 2

In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.

October 5th, 2026

Security: A Way to Be Safe and Unproductive in Radiology

Has the barrage of passwords, PINs and authenticator apps gone around the bend to a point where it hampers efficiency and productivity?

October 4th, 2026

Diagnostic Imaging's Weekly Scan: September 27 — October 3

Catch up on the top radiology content of the past week.

October 3rd, 2026

Emerging Research Insights and New Advances in Neuroradiology

Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.

October 2nd, 2026

MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?

Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.

October 1st, 2026

Current Perspectives on Integrating AI into Radiology

In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.